Browse Drug Recalls
65 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 65 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 65 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Apr 22, 2015 | Lisinopril Tablets USP, 40 mg Tablets, Packaged in A) 100 Count Bottles (NDC:... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Zolpidem Tartrate Tablets, 10 mg Tablets, CIV, Packaged in A) 100 Count Bott... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Metoprolol Succinate Extended-Release Tablets, USP, 50 mg Tablets, Packaged i... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 40 mg Tablets, Packaged in A) 30 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Clarithromycin Tablets, USP, 500 mg Tablets, 60 Count Bottles, Rx Only. Manuf... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 20 mg Tablets, For Repacking Only, Packaged in 6500 ... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Apr 22, 2015 | Famotodine Tablets, USP, 20 mg Tablets, Packaged in A) 30 Count Bottles (NDC... | CGMP Deviations: Firm did not adequately investigate customer complaints. | Class II | Wockhardt Usa Inc. |
| Mar 12, 2015 | Captopril Tablets, USP 12.5 mg, Rx Only, a) 100 count bottles NDC 64679-902-0... | Failed Tablet/Capsule Specifications: out of specification for thickness. | Class II | Wockhardt Usa Inc. |
| Jul 24, 2014 | Wockhardt Metoprolol Succinate Extended-Release Tablets, USP 200 mg, a) 100-c... | Failed Dissolution Specifications: Dissolution failures found during testing of control samples a... | Class II | Wockhardt Usa Inc. |
| Jul 14, 2014 | buPROPion HCl Extended-Release Tablets, USP (SR), 100 mg, 500-count bottle, R... | Failed Impurities/Degradation Products: Out of specification levels of the impurity m-chlorobenzo... | Class III | Wockhardt Usa Inc. |
| Apr 17, 2014 | Wockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-... | Failed Dissolution Specifications: Product was out of specification (OOS) at the 12 month long te... | Class III | Wockhardt Usa Inc. |
| Apr 10, 2014 | Metoprolol Succinate Extended-Release Tablets, USP, 100 mg, 100-count bottle,... | Failed Dissolution Specifications: Failure of dissolution test observed at three month time point. | Class II | Wockhardt Usa Inc. |
| Apr 1, 2014 | Metoprolol Succinate Extended-Release Tablets, USP, 50 mg, 30-count bottle, R... | Failed Dissolution Specifications: failure of dissolution test observed at nine month time point. | Class II | Wockhardt Usa Inc. |
| Nov 27, 2013 | Pantaprazole Sodium Delayed Release Tablets , USP 40 mg, 1000 tablets bottle,... | Failed Dissolution Specifications; 12 month acid dissolution test results were above upper limit ... | Class II | Wockhardt Usa Inc. |
| May 21, 2013 | Zolpidem Tartrate Tablets 5 mg, 10 tablets per blister, 10 blisters per carto... | Unit Dose Mispackaging: This recall event is due to a random undetected packaging issue which cou... | Class II | American Health Packaging |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.